The website of the Clinical Services Journal

European project to tackle antimicrobial resistance

A new project, Combacte-Magnet, has been launched by 33 European academic partners and five pharmaceutical companies, under the IMI antimicrobial resistance research programme ‘New Drugs 4 Bad Bugs (ND4BB)’.

ND4BB has been launched to stimulate antibiotic development in Europe. Combacte-Magnet (Combatting Bacterial Resistance in Europe – Molecules Against Gram-Negative Infections) will bring innovative studies and activities related to prevention and treatment of infections caused by multi-drug resistant Gram-negative bacteria. University Medical Center Utrecht is the project’s managing entity.

The project will investigate a new approach for preventing respiratory infections in intensive care unit (ICU) patients and new treatment options for patients with life-threatening infections due to multi-drug resistant gramnegative bacterium (MDR-GNB).

The project will deliver groundbreaking multinational phase 1, 2 and 3 studies in adult and paediatric ICU patients with MEDI3902, MedImmune’s monoclonal antibody being investigated for the prevention of nosocomial pneumonia caused by a highly drug resistant bacterium, P. aeruginosa. In September 2014, the US Food & Drug Administration granted Fast Track designation to MEDI3902. Hasan Jafri, Combacte-Magnet coordinator, senior director, clinical research and development, infectious disease & vaccines, at MedImmune, said: “As part of MedImmune’s commitment to bringing novel and effective biologic anti-infectives to patients, collaboration with worldrenowned academic partners, such as those involved with Combacte-Magnet, makes the most sense. It is an innovative model for anti-infective development.”

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.
Register

Upcoming Events

Central Sterilising Club - Annual Scientific Meeting 2024

Crowne Plaza at Gerrard’s Cross
15th April 2024 – 16th April 2024

DECON UK 2024

National Conference Centre, Birmingham
17th April 2024

Infection Prevention & Control

National Conference Centre, Birmingham
23rd - 24th April 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Upcoming Events

Central Sterilising Club - Annual Scientific Meeting 2024

Crowne Plaza at Gerrard’s Cross
15th April 2024 – 16th April 2024

DECON UK 2024

National Conference Centre, Birmingham
17th April 2024

Infection Prevention & Control

National Conference Centre, Birmingham
23rd - 24th April 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025